Abstract
u-PA is secreted by the most malignant tumors. As a response to u-PA synthesis surrounding cells synthetize inhibitors of plasminogen activators for tissue protection. Plasminogen activators were found also in earthworm tissue. From the tissue homogenate of earthworm Eisenia foetida the glycolipoprotein mixture named G-90 was isolated. It contains two serine proteases (P I, P II) with fibrinolytic and anticoagulative activities. The fibrinolytic activity of G-90, P I and P II was tested in an in vitro euglobulinic test applied to fibrin clot from blood plasma of patients suffered from malignant tumors. G-90 and above-mentioned proteases applied in this study showed euglobulinic time proportionally with the concentrations of added substances. The influence of G-90 on the fibrinolysis rate does not depend only on its concentration, but depends too on histological type of tissue (organ) where the malignant tumors are located. Enzyme P I and P II do not show this activity.
Similar content being viewed by others
References
Brommer EJP,Emeis JJ,Verheijen JH,et al: Progress in Clinical Fibrinolysis. In: 7 Recent Advances in Blood Coagulation. (Eds. Poller L and Ludlam CA), Churchill Livingstone, 1997, pp. 161-182.
Bugge TH, Flick MJ, Danton MJ, et al: Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci USA 93:5899–5904, 1996.
Cooper DL, Sandler AB, Wilson LD, et al: Disseminated Intravascular Coagulation and Excessive Fibrinolysis in a Patient with Metastatic Prostate Cancer. Cancer 70:656–658, 1992.
Driscoll J and Goldberg AL: The proteasome (multicatalytic protease) is a component of the 1500 kDa proteolytic complex which degrades ubiquitin-conjugated proteins. J Biol Chem 265:4789–4792, 1990.
Gandolfo GM, Conti L and Vercillo M: Fibrinolysis Components as Prognostic Markers in Breast Cancer and Colorectal Carcinoma. Anticancer Res 16:2155–2160, 1996.
Gabazza EC, Taguchi O, Yarnakami T, et al: Coagulation-Fibrinolysis System and Markers of Collagen Metabolism in Lung Cancer. Cancer 70:2631–2636, 1992.
Gabazza EC, Taguchi O, Yamakami T, et al: Evaluating prethrombotic state in lung cancer using molecular markers. Chest 103:196–200, 1993.
Gailani D and Broze GJ: Regulation of coagulation by tissue factor pathway inhibitor. In: 7 Recent Advances in Blood Coagulation. (Eds. Poller L and Ludlam CA), Churchill Livingstone, 1997, pp. 1-17.
Hanss M, Bonvoisin C, Patouillard B, et al: Increased plasma levels of urokinase type plasminogen activator during hepatocellular carcinoma. Fibrinolysis 8:255–260, 1994.
Hrženjak T, Hrženjak M, Kašuba V, et al: A new source of biologically active compounds-earthworm tissue (Eisenia foetida, Lumbricus rubelus). Comp Biochem Physiol I02A:44I-447, 1992.
Hrženjak M, Kobrehel D, Levanat S, et al: Mitogenicity of the earthworm’s (Eisenia foetida) insulin-like proteins. Comp Biochem Physiol 104B:723–729, 1993.
Hrženjak T,Popovic M,Bozič T,et al. Fibrinolytic and antico-agulative activities from the earthworm Eisenia foetida. Comp Biochem Physiol, in press, 1998.
Inndorf S, Bechtel MJ, Reinartz J, et al: Cell density-dependent downregulation of urokinase-type plasminogen activator in normal but not in ransformed human epidermal keratinocytes. Arch Dermatol Res 288,783–785, 1996.
Jeon OH, Moon WJ and Kim DS: An anticoagulant/fibrinolytic protease from Lumbricus rubellus. J Biochem Mol Biol 28:138–142,1995.
Kramer MD, Schaefer B and Reinartz J: Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences. Biol Chem 373:131–141, 1995.
Massignon D, Lepape A, Bienvenu J, et al: Coagulation fibrinolysis balance in septic shock related to cytokines and clinical state. Haemostasis 24:36–48, 1994.
Mihara H, Sumi H, Mizumoto H, et al: Oral administration of erthworm power as a possible thrombolytic therapy. Recent Advances in Thrombosis and Fibrinolysis (Ed Tanaka K): 287–298. Academic Press New York 1990.
Mihara H, Sumi H, Yoneta T, et al: A Novel fibrinolytic enzyme extracted from the earthworm Lumbricus rubellus. Jap J Physiol 41: 461–472,1991.
Nakajima N, Mihara H and Sumi H: Characterisation of potent fibrinolytic enzymes in earthworm, Lumbricus rubellus. Biosci Biotech Biochem 57:1726–1730, 1993.
Popović M, Tiska-Rudman LJ and Hrženjak T: Tissue extract of earthworm Eisenia foetida (G-90) as a blood anticoagulant and fibrinolytic. Vet Arhiv 66:161–167, 1996.
Popović M, Grdiša M, Vuković S, et al: Adhesins of immunoglobulin-like superfamily from earthworm Eisenia foetida. Gen Pharmacol 30:795–800,1997.
Prasad KSM, Sharma BS, Marwaha N, et al: Haemostatic derangement in patients with intracranial tumours. Br J of Neurosurg 8:695–702, 1994.
Sagripanti A,Capri A and Zacharski LR: The pathophysiology of the haemostatic system in cancer patients: Insights gained from studies using plasmatic markers of haemostatic system activation. In: Cancer and Blood Coagulation: basic and clinical aspect. (Eds: Sagripanti A, Carpi A and Zacharski LR), Ets Editrice, 1990, pp 69-92.
Schaefer BM, Stark HJ, Fusenig NE, et al: Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system. Experimental Cell Res 220:415–423, 1995.
Salgado A, Boveda JE, Monasterio J, et al: Inflammatory Mediators and Their Influence on Haemostasis. Haemostasis 24:132–138, 1994.
See WA, Yong X, Crist S, et al: Diversity and modulation of plasminogen activator activity in human transitional carcinoma cell lines. J Urology 151:1691–1696, 1994.
Van-Duijnhoven EM, Lustermans FAT and Van-Wersch JWJ: Evaluation of the coagulation/fibrinolysis balance in patients with colorectal cancer. Haemostasis 23:168–172, 1993.
Wojtukiewich MZ, Zacharski ER, Memoli VA, et al: Interaction with Coagulation and Fibrinolysis Pathways In Situ. Am J Clin Path 93:516–521, 1990.
Zhu CE, Zhang GH, Duan Y, et al: A clinical observation on the treatment of cerebral infarction with Eisenia foetida enzyme. Acta Acad Med Shanghai 20:447–450, 1993.
Yang JS and Ru BG: Purification and characterisation of a SDS-activated fibrinolytic enzyme from Eisenia fetida. Comp Biochem Physiol 118B:623–631, 1997.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
HrŽenjak, T.M., PopoviĆ, M. & TiŠka-rudman, L. Fibrinolytic activity of earthworms extract (g-90) on lysis of fibrin clots originated from the venous blood of patients with malignant tumors. Pathol. Oncol. Res. 4, 206–211 (1998). https://doi.org/10.1007/BF02905250
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02905250